Standard

Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide : an efficient multimodal anti-viral drug. / Drebushchak, T. N.; Kryukov, Yu A.; Rogova, A. I. et al.

In: Acta Crystallographica Section E: Crystallographic Communications, Vol. 73, No. Pt 7, 07.2017, p. 967-970.

Research output: Contribution to journal › Article › peer-review

Harvard

Drebushchak, TN, Kryukov, YA, Rogova, AI & Boldyreva, EV 2017, 'Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide: an efficient multimodal anti-viral drug', Acta Crystallographica Section E: Crystallographic Communications, vol. 73, no. Pt 7, pp. 967-970. https://doi.org/10.1107/S2056989017008155

APA

Drebushchak, T. N., Kryukov, Y. A., Rogova, A. I., & Boldyreva, E. V. (2017). Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide: an efficient multimodal anti-viral drug. Acta Crystallographica Section E: Crystallographic Communications, 73(Pt 7), 967-970. https://doi.org/10.1107/S2056989017008155

Vancouver

Drebushchak TN, Kryukov YA, Rogova AI, Boldyreva EV. Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide: an efficient multimodal anti-viral drug. Acta Crystallographica Section E: Crystallographic Communications. 2017 Jul;73(Pt 7):967-970. doi: 10.1107/S2056989017008155

Author

Drebushchak, T. N. ; Kryukov, Yu A. ; Rogova, A. I. et al. / Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide : an efficient multimodal anti-viral drug. In: Acta Crystallographica Section E: Crystallographic Communications. 2017 ; Vol. 73, No. Pt 7. pp. 967-970.

BibTeX

@article{6c61d244516643b1ba2d119c4df65956,
title = "Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide: an efficient multimodal anti-viral drug",
abstract = "In the title compound, [MeC5H4NCONHCH2C6H5]I or C14H15N2O+·I-, a cation and an anion form an ionic pair linked by a strong N-H·I hydrogen bond. In the crystal, ionic pairs linked by weak C-H·I hydrogen bonds form infinite ribbons along the crystallographic a axis. Polymorphism screening varying crystallization solvents (water, acetone 90%-water, ethanol 90%-water, 2-propanol 90%-water, DMF, DMSO, methanol, acetonitrile) and conditions (solution temperature, heating and cooling protocols) did not reveal any other polymorphs than the one reported in this work.",
keywords = "crystal structure, drug, polymorphism",
author = "Drebushchak, {T. N.} and Kryukov, {Yu A.} and Rogova, {A. I.} and Boldyreva, {E. V.}",
year = "2017",
month = jul,
doi = "10.1107/S2056989017008155",
language = "English",
volume = "73",
pages = "967--970",
journal = "Acta Crystallographica Section E: Crystallographic Communications",
issn = "2056-9890",
publisher = "International Union of Crystallography",
number = "Pt 7",

}

RIS

TY - JOUR

T1 - Crystal structure of 4-benzylcarbamoyl-1-methylpyridin-1-ium iodide

T2 - an efficient multimodal anti-viral drug

AU - Drebushchak, T. N.

AU - Kryukov, Yu A.

AU - Rogova, A. I.

AU - Boldyreva, E. V.

PY - 2017/7

Y1 - 2017/7

N2 - In the title compound, [MeC5H4NCONHCH2C6H5]I or C14H15N2O+·I-, a cation and an anion form an ionic pair linked by a strong N-H·I hydrogen bond. In the crystal, ionic pairs linked by weak C-H·I hydrogen bonds form infinite ribbons along the crystallographic a axis. Polymorphism screening varying crystallization solvents (water, acetone 90%-water, ethanol 90%-water, 2-propanol 90%-water, DMF, DMSO, methanol, acetonitrile) and conditions (solution temperature, heating and cooling protocols) did not reveal any other polymorphs than the one reported in this work.

AB - In the title compound, [MeC5H4NCONHCH2C6H5]I or C14H15N2O+·I-, a cation and an anion form an ionic pair linked by a strong N-H·I hydrogen bond. In the crystal, ionic pairs linked by weak C-H·I hydrogen bonds form infinite ribbons along the crystallographic a axis. Polymorphism screening varying crystallization solvents (water, acetone 90%-water, ethanol 90%-water, 2-propanol 90%-water, DMF, DMSO, methanol, acetonitrile) and conditions (solution temperature, heating and cooling protocols) did not reveal any other polymorphs than the one reported in this work.

KW - crystal structure

KW - drug

KW - polymorphism

UR - http://www.scopus.com/inward/record.url?scp=85023197405&partnerID=8YFLogxK

UR - https://www.elibrary.ru/item.asp?id=31055329

U2 - 10.1107/S2056989017008155

DO - 10.1107/S2056989017008155

M3 - Article

C2 - 28775862

AN - SCOPUS:85023197405

VL - 73

SP - 967

EP - 970

JO - Acta Crystallographica Section E: Crystallographic Communications

JF - Acta Crystallographica Section E: Crystallographic Communications

SN - 2056-9890

IS - Pt 7

ER -

ID: 9561392